fanconi anaemia and blood production · josu de la fuente. st. mary’s hospital. bone marrow...
TRANSCRIPT
![Page 1: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/1.jpg)
Fanconi anaemia
and
blood production
Josu de la FuenteSt. Mary’s Hospital
![Page 2: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/2.jpg)
![Page 3: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/3.jpg)
![Page 4: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/4.jpg)
![Page 5: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/5.jpg)
Bone Marrow biopsy
![Page 6: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/6.jpg)
ASH bank
![Page 7: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/7.jpg)
![Page 8: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/8.jpg)
![Page 10: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/10.jpg)
Start before a patient becomes transfusion dependent: platelets < 40-50 x 109/L
Start at a lower dose: oxymetholone 0.5 mg/kg alternate days
Hb best barometer of response
Discontinued if there is no response by 6 months
Response is relatively slow: 3-6 months
• Fastest: red cells
• Slowest: in platelets
• Neutrophils may respond: most patients with moderate neutropenia seem to get
few bacterial infections.
o Prophylactic antibiotics may help
Higher doses of androgens will often result in higher blood counts but worse side-
effects: up to 2 - 5 mg/kg/day
50% of patients will respond but marked side effects are frequent
Use in girls restricted to low dose therapy: 0.5 -1 mg/kg alternate days
![Page 11: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/11.jpg)
Many patients can decrease dose after response:
• if kept transfusion free
• albeit with platelet counts of 30-90 x 109/L
• minimal side effects
• as low as oxymetholone 0.5 mg/kg every 3 - 5 days
Most patients eventually become resistant: median duration 7 - 8 years
Some patients (perhaps mosaicism) may be able to stop completely
Side effects:
• virilisation (acne, deepening of the voice, facial hair/hair loss)
• growth spurt followed by premature closure of the epiphyses
• behavioural changes
• cholestatic jaundice/transaminitis
• hepatic adenoma or hepatoma, peliosis hepatis
• hypertension
May be irreversible
![Page 12: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/12.jpg)
Platelet counts may fluctuate quite markedly: perhaps in relation to viral infections.
• avoid excessively frequent FBC or micro-managing doses provided transfusion
independent
Hepatic monitoring:
• 3 monthly: LFT
• 6 monthly: USS abdomen
If liver transaminases increase to >3 times normal the dose should be reduced until
blood tests improve.
Hepatic adenomas can resolve after androgens are stopped but may persist for years
Androgens do not prevent progression to MDS or AML
![Page 13: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/13.jpg)
Shlomchik, Nat Rev Immunol 2007
bone marrow transplantation
![Page 14: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/14.jpg)
graft versus host disease
![Page 15: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/15.jpg)
Stepensky, 2011
Fanconi anaemia
fludarabine-based conditioning regimens
![Page 16: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/16.jpg)
Ayas, JCO 2014
survival with evidence of clonal evolution
n = 94
![Page 17: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/17.jpg)
1-year survivors
Peffault de Latour, Blood 2013
![Page 18: Fanconi anaemia and blood production · Josu de la Fuente. St. Mary’s Hospital. Bone Marrow biopsy. ASH bank. Oxymetholone. Start before a patient becomes transfusion dependent:](https://reader030.vdocuments.us/reader030/viewer/2022040302/5e826bd8ec86a34129215b32/html5/thumbnails/18.jpg)
Rosenberg, Blood 2005
Median:• NAS: 33 years• SLH: 18 years
96% 6-years after BMT